Patent
Document Number 2142277 :
*ANTI-CANCER THERAPEUTIC COMPOSITIONS FOR PROPHYLAXIS OR
FOR TREATMENTOF CANCER.*
COMPOSITIONS THERAPEUTIQUES
ANTICANCEREUSES, POUR LA PREVENTION OU LETRAITEMENT DU CANCER
Canadian
Patent 1,338,682 October 29, 1996 - Biologically Active
Undenatured Whey Protein Concentrate As Food Supplement
U.S. Patents
The US Government has issued a similar
patent. Medicare & Medicaid consider this product a treatment
for cancer, fibromyalgia, chronic fatigue & a number of other
maladies.On-going research in all these fields is yeilding positive
results.
United States Patent 5,888,552 Bounous , et al. March 30,
1999
Anti-cancer therapeutic compositions containing whey protein
concentrate
Abstract: This invention relates to a
method of treatment of patients having lesions resulting from cancer
cells and to an application as an anti-cancer composition of
undenatured whey protein concentrate.
United
States Patent 5,456,924 Bounous , et al. * October 10,
1995
Method of treatment of HIV-seropositive individuals
with dietary whey proteins
Abstract: Undenatured whey
protein concentrate is administered to HIV-seropositive individuals to
elevate their blood mononuclear cells, glutathione (GSH) level, body
weight and sense of well being. In addition T-helper cells
concentration and their T-helper cells/T-suppressor cells ratio are
slightly elevated.
United
States Patent 5,290,571 Bounous , et al. * March 1, 1994
Biologically active whey protein concentrate
Abstract: The present invention is concerned with a
whey protein composition comprising a suitable concentration of whey
protein concentrate wherein the whey protein concentrate contains
proteins which are present in an essentially undenatured state and
wherein the biological activity of the whey protein concentrate is
dependent on the overall amino acid and small peptides pattern
resulting from the contribution of all its protein components and a
method of producing said whey protein composition. The invention also
relates to several applications of said composition.
United
States Patent 5,230,902 Gold , et al. July 27, 1993
Undenatured
whey protein concentrate to improve active systemic humoral immune
response
Abstract: This invention provides a method of
improving the humoral immune response or increasing the concentration
levels of glutathione in mammals, which comprises administering orally
to a mammal a therapeutically or a prophylactically effective amount
of undenatured whey protein concentrate which has a biological
activity based on the overall amino acid and associated small peptides
pattern resulting from the contribution of all its protein components.
A method for improving the humoral immune response in mammals also is
disclosed which comprises administering orally to a mammal the
combination of a vitamin supplement containing vitamin B.sub.2 in an
amount in excess of minimum daily requirements and an effective amount
of undenatured whey protein concentrate. This invention further
provides a dietary supplement for a mammal which comprises an
effective amount of vitamin B.sub.1, and B.sub.2 and a therapeutically
or prophylactically effective amount of whey protein supplement.
United
States Patent 5,451,412 Bounous , et al. * September 19,
1995
Biologically active undenatured whey protein concentrate as
food supplement
Abstract: The present invention is
concerned with a whey protein composition comprising a suitable
concentration of whey protein concentrate wherein the whey protein
concentrate contains proteins which are present in an essentially
undenatured state and wherein the biological activity of the whey
protein concentrate is dependent on the overall amino acid and small
peptides pattern resulting from the contribution of all its protein
components and a method of producing said whey protein composition.
The invention also relates to several applications of said
composition.
United States Patent ™
United States Patent
5,846,939 December 8, 1998 - Use of a Decapeptide with
Benzodiazepine-Type Activity for Preparing Medicines and Food
Supplements
The present invention relates to the use of the
decapeptide having the amino acid sequence of SEQ ID NO.:1 ##STR1## in
the preparation of medicines having benzodiazepine-type activity,
particularly useful for the treatment of convulsions and anxiety. The
invention also relates to phamaceutical compositions, food
supplements, and foodstuffs for special diets containing the said
decapeptide.
